Clinical Trials
2 trialsNCT03793166 2026-05-29
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06476639 2026-03-24
ANVU
Queensland Centre for Gynaecological Cancer
Phase 3 Not yet recruiting